PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-70.60%
Both yoy net incomes decline, with JD at -550.60%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
9.17%
D&A growth of 9.17% while JD is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-176.42%
Negative yoy deferred tax while JD stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
1.04%
SBC growth while JD is negative at -3.79%. John Neff would see competitor possibly controlling share issuance more tightly.
94.91%
Working capital change of 94.91% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
43.33%
AR growth of 43.33% while JD is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-1821.05%
Negative yoy inventory while JD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
159.98%
AP growth of 159.98% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
39.48%
Growth of 39.48% while JD is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-14.58%
Negative yoy while JD is 219.63%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
29.47%
Operating cash flow growth below 50% of JD's 201.31%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-7.60%
Negative yoy CapEx while JD is 10.55%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-500.00%
Negative yoy acquisition while JD stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-26.20%
Negative yoy purchasing while JD stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
53.71%
Liquidation growth of 53.71% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
9.66%
We have some outflow growth while JD is negative at -98.61%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-5.37%
Both yoy lines negative, with JD at -87.77%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
17.24%
Debt repayment growth of 17.24% while JD is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.